Clik here to view.
23andMe Releases Results For Major Alzheimer’s Risk Marker
Some important news this morning in the consumer genetics space: personal genomics company 23andMe has just announced the availability of risk information for Alzheimer’s disease using two markers in...
View ArticleAdvantages of the Genome Factory
A couple of weeks ago I blogged about my visit to Mountain View-based Complete Genomics, a DNA sequencing company with a novel service-based approach (rather than selling sequencing instruments they...
View ArticleLast chance: let the FDA know why you want direct access to your own genome
Regular readers of this blog will be very familiar with the fledgling personal genomics industry, a diverse set of companies offering to sell you information about your ancestry and disease risk based...
View ArticleMy submission to the FDA on the regulation of personal genomics
I noted last week the opportunity for public submissions to the FDA on the regulation of personal genomics (sadly, the deadline for submission has now passed). I put together my own submission over the...
View ArticleClik here to view.
Yet another trial by press release for personal genomics
A press release launched yesterday by the European Society of Human Genetics announces two upcoming presentations at the Society’s annual meeting next week, both critical of personal genomics. How...
View ArticleClik here to view.
How accurate is the new Ion Torrent genome, really?
New sequencing technology Ion Torrent has made a splash with a paper in today’s issue of Nature. There’s no question the high-impact publication is a massive boost for the young platform, now nestled...
View ArticleClik here to view.
Longevity genetics study retracted from Science
In July last year I wrote about some fairly glaring flaws in a paper published in Science on the genetics of extreme longevity. At the time, potential problems with the paper had been flagged in an...
View ArticleClik here to view.
Personal genomics: no longer just for white folks
Note: I removed the word “rich” from the title following comments below about potential misinterpretation This morning personal genomics company 23andMe launched an initiative designed to shift the...
View ArticleClik here to view.
Will Prenatal Screening for Serious Diseases Rob Us of Our Creativity?
David Goldstein has a commentary in this week’s issue of Nature on the potential impact of prenatal genetic screening on society (subscription required, unfortunately). The major issues it raises...
View ArticleClik here to view.
Gene Therapy Emerges From Disgrace to Be the Next Big Thing, Again
A genetically modified virus laid waste to James Wilson's career. Now a second one could bring him to redemption. The post Gene Therapy Emerges From Disgrace to Be the Next Big Thing, Again appeared...
View Article